A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment for menopause.

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

US health authorities are set Thursday to reassess Hormone Replacement Therapy (HRT), a treatment used by menopausal women ...

These are the same top two reasons cited by users of FDA-approved hormone therapy (70% and 28%, respectively), reported NAMS Executive Director Emeritus Margery Gass, MD.

The Endocrine Society issued a position statement in October 2006 asking for greater oversight of all "bioidentical" hormones, whether FDA-approved or compounded, to further understand the safety ...

A new study suggests that hormone therapy, often used to ease symptoms of menopause like hot flashes and night sweats, may ...